Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

rTMS for Military TBI-related Depression

NCT: NCT05426967 · RECRUITING

NCT IDNCT05426967
StatusRECRUITING
Start Date2024-12-16
Completion2026-12-31

Brief Summary

The purpose of this study is to investigate the efficacy, safety, and tolerability of two dorsolateral prefrontal cortex (DLPFC) repetitive transcranial magnetic stimulation (rTMS) protocols to alleviate symptoms of depression in United States (U.S.) military service members and veterans with a history of concussion/mild traumatic brain injury (TBI).

Frequently Asked Questions

What is rTMS for Military TBI-related Depression?

rTMS for Military TBI-related Depression is a clinical trial registered under NCT05426967. Current status: RECRUITING.

What is the status of NCT05426967?

The current status of NCT05426967 (rTMS for Military TBI-related Depression) is: RECRUITING.

When did rTMS for Military TBI-related Depression start?

rTMS for Military TBI-related Depression started on 2024-12-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.